Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-s-study-sees-small-intestinal-cancer-incidence-rising-globally-and-in-hong-kong-higher-incidence-observed-in-high-income-countries
https://www.med.cuhk.edu.hk/press-releases/cuhk-s-study-sees-small-intestinal-cancer-incidence-rising-globally-and-in-hong-kong-higher-incidence-observed-in-high-income-countries

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

Small intestinal cancer is a rare form of the disease. The average five-year survival rate for early-stage patients is about 80%, but it drops to only 40% for late-stage cases. Despite continuous efforts by the medical community to research small intestinal cancer and push for early detection, there is a lack of global epidemiological data to help them understand the specific patterns and prevalence of the disease. The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has conducted a study with the Association of Pacific Rim Universities (APRU) to investigate the global distribution, risk factors and epidemiological trends of small intestinal cancer. The results showed that the incidence of small intestinal cancer has also substantially increased globally and the number of new cases in Hong Kong has doubled in the past decade.

 

The study also found the incidence of small intestinal cancer was higher in high-income jurisdictions, and was closely related to per capita gross domestic product (GDP) levels, the human development index (HDI), and the prevalence of unhealthy lifestyle habits, metabolic diseases and inflammatory bowel disease (IBD) at the country level. The researchers recommend that risk factor control and early cancer detection should be implemented for high-risk populations to mitigate the rise in small intestinal cancer. Details of the study have been published recently in the top international medical journal Gastroenterology.

 

Hong Kong has the world’s highest small intestinal cancer incidence, with the number of cases doubling in the past decade

 

Small intestinal cancer’s common symptoms include abdominal pain, loss of appetite, gastrointestinal bleeding, weight loss, small intestine perforation, intestinal obstruction and obstructive jaundice. Due to the challenges of detecting it, small intestinal cancer is often diagnosed at an advanced stage when it has already metastasised, resulting in relatively poorer treatment outcomes.

 

Currently, the crude incidence rate of small intestinal cancer in Hong Kong is 2.2 cases per 100,000 individuals, with an age-standardised incidence rate of 1.0. These rates indicate a relatively high incidence compared to the global average. According to data from the Hospital Authority, the number of new cases of small intestinal cancer in Hong Kong has nearly doubled over the past decade, from 88 cases in 2011 to 164 in 2020. There is also an upward trend in the number of deaths, rising from 38 cases in 2011 to 60 in 2020.

 

Developed regions such as North America, Oceania and Northern Europe have the highest incidence

 

The research team retrieved data about cancer incidence and the prevalence of different risk factors from international databases such as the Global Cancer Observatory, Cancer Incidence in Five Continents Plus and Global Burden of Disease. They found that the disease burden of small intestinal cancer varied across regions, with North America, Oceania and Northern Europe having the highest incidence (see details in Table 1). In addition, the disease burden of small intestinal cancer was proportional to GDP, HDI and the prevalence of smoking, alcohol consumption, unhealthy diets, physical inactivity, obesity, diabetes, lipid disorders and IBD. This implies that a country or region with a higher level of those risk factors will have higher morbidity from small intestinal cancer.

 

Table 1-Top three regions with highest age-standardised incidence of small intestinal cancer

 

Top three regions with highest incidence of small intestinal cancer

Standardised incidence (per 100 000)

North America

1.4

Oceania

0.96

Northern Europe

0.94

Global small intestinal cancer incidence is showing an upward trend, with the highest increase observed in elderly patients
 

Small intestinal cancer incidence has been substantially increasing globally over the past decade, with the highest increase observed in the older population. Using the “Average Annual Percentage Change (AAPC[1])” for comparison, the largest increase in incidence rate among people aged 50 or above was found in Poland, followed by India and Thailand (see details in Table 2).

 

Table 2-Top three countries with highest AAPCs of small intestinal cancer incidence among elderly aged 50 or above

 

Country

Average Annual Percentage Change (AAPC)

Poland

21.4

India

12.0

Thailand

10.3

 

Professor Martin Wong and Dr Jason Huang

Professor Martin Wong (left) and Dr Jason Huang

Dr Jason Huang Junjie, the first author of the study and Research Assistant Professor from The Jockey Club School of Public Health and Primary Care at CU Medicine, said, “The incidence of small intestinal cancer varies by region, which may be associated with differences in healthcare standards, lifestyle habits, metabolic disorders and the prevalence of IBD. Our study provides the most up-to-date and comprehensive evidence on the global distribution, risk factors and trends of small intestinal cancer. Policymakers in different regions should implement evidence-based, targeted prevention strategies to control the relevant risk factors.”

 

Professor Martin Wong Chi-sang, the senior corresponding author of the study, from The Jockey Club School of Public Health and Primary Care at CU Medicine, added, “Genetic factors account for only about 20% of small intestinal cancer cases. The global incidence rate of small intestinal cancer is increasing, likely due to the rise in environmental risk factors, and improved medical diagnostics leading to higher detection rates. Future studies should explore the reasons behind these epidemiological transitions, so that they can provide insights on the cause and prognosis.”

 

About this study, a collaboration with the APRU

 

This study is a collaboration with Professor Mellissa Withers, the Director of the APRU Global Health Programme, Keck School of Medicine, University of Southern California. The APRU (https://apru.org/) was established in Los Angeles in 1997 by the presidents of UCLA, Berkeley, Caltech and the University of Southern California. It now has a membership of 60 leading research universities from around the Pacific Rim. CUHK is an important member of the APRU, and Professor Martin Wong Chi-sang and Dr Jason Huang Junjie are currently the Co-Chairs of the Non-Communicable Diseases (NCD) Global Health Working Group for the network.


[1] AAPC is a measure of the overall changes in cancer incidence for a specific period. For example, if the incidence AAPC of a certain cancer in a country is five for the past 10 years, it means that the incidence in that country increased 5% on average each year over the 10-year period.

More Press Releases

CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

Research
CUHK proves the eHealth App’s Health Management module helps promote  self-management of diabetes

CUHK proves the eHealth App’s Health Management module helps promote self-management of diabetes

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service
CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

Research
Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award  Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Awards and honors
CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

Research
CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

Research
CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CUHK study sees a rising trend of mesothelioma incidence in females and a higher incidence in high-income countries

CUHK study sees a rising trend of mesothelioma incidence in females and a higher incidence in high-income countries

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK and Hong Kong Association of Careers Masters and Guidance Masters Survey Shows Concerns about Hong Kong Students Suffering from Irritable Bowel Syndrome

CUHK and Hong Kong Association of Careers Masters and Guidance Masters Survey Shows Concerns about Hong Kong Students Suffering from Irritable Bowel Syndrome

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

Research
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

Research
Hong Kong’s waters benefit health and wellbeing

Hong Kong’s waters benefit health and wellbeing

Research
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

Research
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.